logo
Share SHARE
FONT-SIZE Plus   Neg

Achillion To Raise $41.8 Mln Through Registered Direct Offering

Achillion Pharmaceuticals, Inc. (ACHN) said Thursday that it has entered into a definitive agreement with funds managed by QVT Financial LP for the sale of about 6.37 million shares of its common stock.

The investors have agreed to purchase the shares of common stock at a price of $6.57 per share, resulting in gross proceeds to Achillion, before deducting estimated offering expenses, of about $41.8 million.

The sale and issuance of the shares is expected to close on or about September 4.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
BlackBerry has launched its second Android smartphone DTEK50, which the struggling company touts as the most secure Android smartphone ever. DTEK50 is BlackBerry's second smartphone powered by Android, following the PRIV. The device actually shares its design and hardware specifications with the recently... Mobileye (MBLY), a self-driving car technology company, Tuesday announced that it is ending its partnership with electric car marker Tesla Motors Inc. (TSLA) for the development of auto pilot program. Shares of Mobileye plunged about 8 after the news. Mobileye announced the decision to part ways with... General Mills has announced another expansion to its flour recall in response to four new illnesses that were linked to a possible E. Coli outbreak. The latest recall covers several varieties of Signature Kitchens and Gold Medal flour produced through February 10. General Mill had first announced...
comments powered by Disqus
Follow RTT